78
微微微微微微微 微微微微微微 微微微微微 ( 微 230 微 )

微生物及免疫學 主題七: 抗原抗體與免疫反應 ( 共 230 題 )

Embed Size (px)

DESCRIPTION

微生物及免疫學 主題七: 抗原抗體與免疫反應 ( 共 230 題 ). A 01. 下列何種細胞會分泌抗體? (A) 漿細胞  (B) 巨噬細胞  (C) 幹細胞  (D) 單核球細胞。  ( '01 師檢) B 02. 病原菌感染後,最早出現之免疫球蛋白是哪一種? (A) IgG (B) IgM (C) IgA (D) IgE 。  ( '01 師檢) B 03. 能造成體液性免疫及細胞性免疫反應之細胞分別為何? (A)NK 細胞與 B 細胞  (B)B 細胞與 T 細胞  (C)T 細胞與 NK 細胞  (D)T 細胞與巨噬細胞。  ( '01 師檢). - PowerPoint PPT Presentation

Citation preview

1

(230)

A01.(A)(B)(C)(D)'01

B02.(A)IgG(B)IgM(C)IgA(D)IgE'01

B03.(A)NKB(B)BT(C)TNK(D)T'01

D04.Mycobacterium tuberculosis(A)(B)(C)(D)'01

A05.inactivated(A)(B)(C)(D)'01

B06.IgA(A)(B)(C)(D)'01

A07.(A)23(B)(C)(D)'01

C08.B(A)MHC-(B)MHC-(C)(D)'01

B09.IgG(A)(B)ELISA(C)(D)X'01

D10.(A)gramule(B)Fc R(C)(D)T'01

D11.T(A)B(B)(C)(D)B'01

A12.(A)(B)(C)pH2.5(D)3 M'01

B13.2 IL-2(A)B(B)T(C)(D)'01

D14.(A)Fab(B)Fab'2(C)Fb(D)Fc'01

B15.CD4TTH2(A)IL-2(B)IL-4(C)IL-6(D)IL-8'01 B16.complement(A)chemotaxis(B)(C)mast cells(D)opsonization'01

B17.(A)(B)(C)(D)'01

C18.(A)(B)(C)(D)'01 C19.B(A)T(B)costimulting molecule(C)(D)APC'01

B20.(A)IgA(B)IgE(C)IgG(D)IgM'01

D21.vaccine(A)toxoid(B)attenuated bacteria(C)inactivated viruses(D)antibodies'01 C22.T(A)HIV(B)(C)(D)CD3'01

B23.IgEmast cell(A)(B)chemical mediators(C)complement fixation(D)agglutination'01

C24.ARh (A)anti A, anti Rh(B)anti A(C)anti B(D)anti B, anti Rh'01

D25.T(A)apoptosis(B)TC(C)THB(D)TCMHC'01

D26.(A)(B)(C)(D)'01

A27.(A)(B)(C)secretory component(D)'02

B28.T(A)1interleukin-1; IL-1(B)2interleukin-2; IL-2(C)3interleukin-3; IL-3(D)interferon '02

D29.TB(A)(B)cytokine(C)CD40(D)'02

B30.natural killer cells(A)TCD3(B)large granular lymphocytes(C)target cell(D)CD8'02

C31.ELISABHBsAg(A)HBsAg(B)50100 ml/gm(C)anti-HBsHBsAg(D)C'02

A32.Fc(A)T(B)phagocytosis(C)opsonization(D)mast cell'02

B33.T(A)CD48(B)CD4(C)CD8(D)CD48'02

A34.(A)T(B)B(C)TB(D)'02

C35.(A)(B)(C)(D)'02

B36.(A)HIV(B)(C)recombinant DNA(D)'02

B37.BIgEcytokine(A)IL-5(B)IL-4(C)IFN-(D)TNF-'02

B38.HATHAT(A)hypoxanthine(B)aminopterin(C)thymidine(D)'02

C39.(A)(B)(C)(D)'02

B40.CD3IL-4IL-5IL-10(A)(B)B(C)(D)T'02

A41.clonal selection(A)B(B)cytokines(C)T(D)'02

A42.B(A)(B)CD2(C)CD3(D)CD8'03

B43.primary(A)(B)(C)(D)'03

A44.(A)(B)(C)(D)'03

A45.(A)T(B)B(C)(D)'03

A46.(A)(B)(C)(D)'03

C47.BCG(A)(B)(C)(D)'03

A48.(A)(B)(C)(D)'03

B49.(A)IgM(B)TB(C)IgE(D)'03

C50.23IgG(A)(B)(C)(D)cross reactivity'03

B51.chemotaxismast cell(A)C3aC4a(B)C3aC5a(C)C4aC5a(D)C4aC2a'03

C52.cytokines(A)(B)(C)T(D)paracrineautocrine '03

D53.tumor necrosis factor-TNF-(A)adhesion molecules(B)intracellular pathogen(C)hematopoiesis(D)killer cell'03

C54.(A)IgG(B)IgM(C)IgA(D)IgE'03

A55.(A)cytokines(B)(C)(D)'03

AD 56.macrophagecytokine(A)IL-4(B)IL-6(C)IL-8(D)IFN-'03 C57.BCG(A)BCG(B)BCG(C)BCGtuberculin(D)BCG'03

D58.(A)IgA(B)IgD(C)IgG(D)IgM'03

A59.(A)(B)(C)(D)'03

D60.NK cell(A)TT lymphocyte(B)BB lymphocyte(C)monocyte(D)large granular lymphocyte'03

A61.B(A)(B)(C)(D)'03

C62.(A)(B)(C)(D)'03

D63.(A)(B)(C)HAT(D)'03

D64.(A)pH 2.0(B)pH 11.5(C)(D)pH 7.0'03

A65.BB(A)(B)(C)(D)'03

D66.(A)(B)(C)(D)'03

C67.(A)neutrophils(B)humoral immunity(C)TT lymphocytes(D)complement'03

D68.Tcytotoxic T lymphocyte(A)CD3CD4T(B)IL-4(C)CD8(D)MHC class I'03

A69.TH1TH2cytokinescytokine(A)GM-CSF(B)IL-12(C)IL-2(D)IL-5'03

D70.NK cell(A)(B)(C)(D)IgG Fc'03

C71.(A)1(B)23(C)57(D)'03

B72.(A)T(B)B(C)(D)'04

C73.lactoferrin(A)T(B)B(C)(D)'04

B74.hypogammaglobulinemia(A)phytohemagglutinin(B)IgG(C)(D)'04

A75.(A)(B)(C)(D)'04

D76.(A)(B)Van der Waal's(C)(D)'04

A77.B(A)cortex(B)paracortex(C)red pulp(D)medulla'04

C78.(A)(B)(C)(D)'04

D79.attenuated(A)measles(B)mumps(C)rubella(D)diphtheria'04

A80.classical pathway(A)C1(B)C3a(C)C3b(D)C5'04

D81.innate immunity(A)T(B)B(C)(D)'04

C82.T(A)(B)T(C)(D)costimulating molecule'04

A83.cytokine(A)4(B)(C)(D)12'04

C84.interferon; IFN(A)IFN fibroblast(B)IFN leukocyte(C)IFN T(D)'04

D85.cytokine(A)80 kDa(B)cytokine(C)cytokine(D)cytokine'04

C86.innate immunityadaptive immunity(A)(B)(C)(D)'04

D87.haemolytic disease of newborn(A)RhRh(B)(C)Rhrhogam(D)bilirubin'04

C88.IgG(A)(B)(C)(D)'04

D89.TH(A)(B)(C)epitopes(D)MHC class'04

C90.plasma cells(A)isotypes(B)(C)B(D)IgG2'04

D91.(A)(B)(C)(D)'04

B92.antibody-dependent cell mediated cytotoxicity; ADCC(A)TTCR(B)FcR(C)(D)'04

A93.DPT(A)(B)(C)(D)'04

C94.(A)(B)(C)(D)'04

D95.(A)0.15 mg/mL(B)0.010.5 mg/mL(C)0.15 g/mL(D)150 ng/mL'04

B96.(A)(B)(C)(D)'04

C97.complement system(A)C1q(B)C3b(C)CD2(D)decay accelerating factor'04

B98.Tcytotoxic T cells(A)target cellDNA(B)51Cr(C)(D)'04

A99.B(A)(B)(C)(D)'04

C100.T(A)CD1(B)CD4(C)CD8(D)CD19'04

A101.carcinoembryonic antigenCEA(A)(B)(C)(D)'04

D102.poliomyelitispoliovirus vaccine(A)IgA(B)IgA(C)IgA(D)IgM'04

B103.TTH1 cellscytokine(A)IL-2(B)IL-4(C)IFN-(D)TNF-'04

D104.mast cells(A)(B)(C)(D)'04

A105.(A)(B)(C)(D)T'04

C106.IgMMHC classCD40(A)(B)TC(C)(D)'04

D107.(A)(B)(C)(D)'04

D108.(A)B(B)(C)(D)'05

B109.(A)IgAIgG(B)IgGIgA(C)IgA(D)IgG'05

C110.cytokine(A)(B)TTH1TH2(C)TH1TH2(D)'05

A111.(A)MHCB(B)MHC(C)MHC(D)IDDMDR3DR4'05

C112.professional antigen-presenting cell(A)CD4T(B)neutrophil(C)macrophage(D)mast cell'03'05

C113.phagocytosis(A)(B)particulate(C)(D)'05

A114.TT helper cellmacrophageclasscytokineT(A)IL-1(B)IL-2(C)IL-4(D)IL-5'05

C115.IL-2IL-2R (A) (B) (C) (D) '05

D116.Tsurface antigen(A)TMHC class(B)TTT cell receptor(C)TEpstein-Barr(D)TCD4TCD8'05

A117.IFN interferon gammamacrophage(A)NK cells(B)(C)(D)'05

A118.cytokineCD4TH1(A)interleukin-2(B)interleukin-4(C)interleukin-5(D)inter-leukin-10'03'05

B119. interferon(A)(B)macrophage(C)TH1(D)TH2'05

A120.IgA(A)(B)(C)(D)DNA'05

C121.lymphoid progenitor(A)T(B)B(C)monocyte(D)natural killer cell'05

D122.cytokineinterleukin-12(A)fibroblast(B)T(C)B(D)macrophage'05

A123.antigen-presenting(A)T(B)B(C)macrophage(D)dendritic cell'05

B124.VDJCrearrangement(A)VDVDJVDJC(B)DJVDJVDJC(C)JCDJCVDJC(D)VCVDCVDJC'05

D125.(A)C12345(B)C13579(C)C23468(D)C56789'05

C126.(A)(B)(C)(D)'05

D127.(A)IgA(B)IgG(C)IgM(D)IgE'05

B128.BHBV(A)HBs(B)HBs(C)(D)'05

C129.M(A)(B)(C)(D)Peyer's patches'05

B130.IgG(A)(B)(C)(D)'05

C131.(A)(B)immune complex(C)(D)membrane attack complextarget cell'05

A132.(A)(B) T (C) B (D)'05

C133.(A)NK cells(B)monocytes(C) Langerhans' cells(D) CD3 '05

D134.T(A)(B)70(C)TCD3(D)TCD4'05

C135.lymphocyteinterferonimmuneinterferon(A) IFN- (B) IFN- (C) IFN- (D) IFN- '05

C136.(A)A(B)M(C)G(D)D'06

B137.(A)(B)T(C)(D)'06

C138.(A)(B)(C)(D)'06

C139.cytokines(A)IL-1 and IL-2(B)IL-3 and IL-4(C)IL-1 and TNF-(D)IL-3 and IL-8'06

B140.CD3(A)neutrophil(B)Tcytotoxic T lymphocyte(C)dendritic cell(D)BB lymphocyte'06

D141.secondary immune response(A)(B)(C)IgG(D)antibody affinity'06

B142.TB(A)SLE(B)SCID(C)(D)'06

B143.(A)(B)(C)interferon(D)'06

D144.agglutinationagglutinin(A)IgA(B)IgD(C)IgG(D)IgM'06

C145.DPT(A)(B)(C)(D)'06

C146.Tcytotoxic T cellscytokine(A)IL-5(B)IL-6(C)IL-2(D)IL-13'06

B147.(A)classical pathway(B)lectinlectin pathway(C)alternative pathway(D)tyrosine kinasetyrosine kinase pathway'06

A148.(A)CD48(B)CD4(C)CD8(D)CD48'06

B149.(A)(B)(C)Di George(D)'07

C150.(A)epitope(B)Fab(C)(D)'07

B151.(A)(B)IgA(C)(D)'07

A152.(A)Poxvirus(B)(C)(D)'07

C153.T(A)B(B)B(C)B(D)B'07

D154.class I MHC(A)(B)Tclass I MHC(C)class I MHC(D)class I MHCHLA-DPHLA-DQHLA-DR'07

A155.(A)(B)(C)(D)mast cell'07

C156.(A)B(B)T(C)(D)'07

AD 157.(A)classsubclassheavy chainlight chain(B)heavy chainlight chainconstant region(C)variable region(D)Bclass switchingantigen binding sites'07

C158.(A)(B)(C)(D)Tcytotoxic T cell'07

B159.(A)(B)(C)(D)'07

C160.(A)chemotaxin(B)opsonin(C)membrane attack complex(D)anti-toxin'07

B161.(A)(B)B(C)(D)'07

C162.(A)(B)(C)(D)'07

A163.CD8 T(A)class MHC(B)class MHC(C)class MHC(D)perforin'07

D164.(A)(B)T(C)(D)'07

A165.IgMIgG(A)(B)T(C)B(D)B'07

B166.(A)macrophage(B)lymphocyte(C)natural killer cell(D)dendritic cell'07

A167.B(A)(B)(C)(D)'07

D168.(A)(B)class MHC(C)(D)'07

B169.(A)BCG(B)DPT(C)MMR(D)OPV'07

A170.(A)(B)(C)(D)'05'08

D171.(A)(B)(C)TTC(D)TTH'08

C172.(A)(B)(C)(D)'08

D173.(A)(B)(C)(D)T'08

A174.TH1(A)IFN-(B)4IL-4(C)10IL-10(D)TGF-

C175.B(A)CD1(B)CD3(C)CD19(D)MHC class '08

C176.(A)IgM(B)IgG(C)IgA(D)IgE'08

D177.myeloid cellhematopoietic stem cell(A)1IL-1(B)3IL-3(C)4IL-4(D)TGF-'08

B178.(A)(B)IgG(C)(D)'05'08

B179.(A)(B)(C)T(D)B'08

C180.(A)(B)(C)pH(D)'08

B181.T(A)CD4CD8(B)MHC(C)HLA(D)'08

C182.T(A)class I MHCpeptide(B)(C)(D)apoptosis'08

A183.(A)IgG1(B)IgM(C)IgA1(D)IgD'08

D184.(A)B(B)T(C)T(D)'08

B185.cytokineBIgE(A)1IL-1(B)4IL-4(C) IFN(D)IFN'08

D186.(A)mast cell(B)microglial cell(C)Langerhan's cell(D)monocyte'08

D187.(A)(B)(C)(D)'09

C188.(A)(B)(C)(D)'09

A189.cytokines(A)(B)(C)(D)'09

B190.B(A)(B)(C)classIgMIgM(D)B'09

B191.antigen presentation(A)B(B)(C)dendritic cell(D)'09

C192.(A)(B)(C)(D)'09

B193.major histocompatibility complex; MHCD(A)class I MHC(B)class II MHC(C)class III MHC(D)'09

C194.(A)(B)(C)(D)opsonization'09

C195.(A)TTC(B)TTH(C)(D)B'09

B196.(A)IgM(B)IgG(C)TTC(D)'09

C197.(A)mast cell(B)B(C)(D)T'09

D198.IgG(A)IgM(B)(C)(D)'09

A199.(A)dendritic cell(B)neutrophil(C)mast cell(D)TT-lymphocyte'09

B200.B(A)fetal liver(B)thymus(C)bone marrow(D)spleen'09

C201.IgEreceptor(A)den-dritic cell(B)TT-lymphocyte(C)mast cell(D)neutrophil'09

A202.(A)V(B)(C)C(D)C'09

B203.(A)B(B)T(C)B(D)'09

D204.(A)(B)(C)(D)'10

A205.(A)(B)(C)(D)'10

A206.(A)IgA(B)IgE(C)IgG(D)IgM '10

B207.(A)IgM(B)IgG(C)IgA(D)IgE'05'10

B208.TT cell receptor; TCR(A)TTCR(B)TCRCD3(C)peptide antigenTCR(D) TCR TCRT'10

A209.T(A)(B)(C)IL-4TH1(D)'10

A210.(A)B(B)T(C)(D)'10

B211.(A)(B)TTC(C)(D)'10

B212.T(A)(B)(C)(D)'10

D213.(A)(B)(C)(D)'10

B214.classical pathway(A)(B)(C)(D)cytokine'10

D215.(A)(B)(C)(D)'10

C216.T(A)FcFc receptor(B)class MHC(C)class MHC(D)class MHC'10

D217.germinal center(A)(B)dendritic cell(C)T(D)B'10

A218.subunit(A)B(B)(C)(D)'10

C219.(A)(B)(C)(D)5'11

C220.(A)(B)(C)(D)'11

C221.(A)(B)(C)T(D)B'11

B222.1IL-1(A)TTS(B)(C)TTH(D)TTC'11

B223.(A)B(B)T(C)(D)'11

A224.(A)TTCRB(B)(C)IgM(D)B'11

C225.(A)(B)B(C)(D)'11

C226.(A)TCD4(B)Gpb/a(C)B(D)LTB4'11

C227.LFA-1lymphocyte functional antigen-1(A)VCAM-1vascular cell adhesion molecule-1(B)fibronectin(C)ICAM-1intercellular adhesion molecule-1(D)C3b'11

A228.mononuclear cell or mononuclear phagocyte(A)monocyte(B)neutro-phil(C)eosinophil(D)lym-phocyte'11

C229.B(A)CD4(B)CD8(C)CD19(D)CD59'11

A230.(A)(B)(C)(D)'11